14^th International Conference on Pharmaceutics and drug safety August 06-07, 2021 London, UK

Qingfu Zhu has completed his Ph.D. in Pharmacy, (Advisor: Prof. Dr. Gerhard Scriba) University of Jena, Postdoc in the Bioengineering, University of Kansas and Postdoc in the Chemistry Department, Wichita State University. At Present he is Professor at Wenzhou Medical University. His Current Research Interests are Develop microfluidic-based method for extracellular vesicle (EV) research including cancer early detection, virus latency-reactivation via EV communication, and efficient drug delivery via EV. He has published papers in reputed journals.

Ø Microfluidic method for extracellular vesicles (exosomes) detection, isolation and engineering Ø Microfluidic engineering of 3D cultured cells and tissues Ø Design and optimize analytical system, such as integrated flow-gated CE system Ø Quantitative analysis of biomolecules and drugs using CE, HPLC, MS, etc

Dr Amit Bhatia is working as Associate Professor at Department of Pharmaceutical Sciences & Technology, Maharaja Ranjit Singh Punjab Technical University, Bathinda, Punjab. He is an alumnus of Panjab University, Chandigarh. He has been working in the area of drug delivery and formulation development. He was part of team for the development and technology transfer of 3 novel drug carriers based products. He has 2 patent granted, 3 patents (filed) and 36 research/review articles published in prestigious periodicals. He recipeient of various awards and honours. Dr Bhatia is committed to execute viable and translation research for improving public health.

Drug delivery systems and strategies, Intellectual property right, Clinical, Tech-transfers, Teaching and learning, Policy formulation.

Dr Shruti Chopra acquired her PhD and M.Pharm degrees from Katholieke Universiteit Leuven, Belgium and B. Pharm from Birla Institute of Technology, Mesra, India. She is currently working as Assistant Professor at Amity Institute of Pharmacy, Amity University, Noida, India. She is handling various UG, PG and PhD projects. She is recipient of “Young Scientist” project grant from Science and Engineering Research Board, Department of Science and Technology, Government of India. Her area of research is pharmaceutical analysis particularly liquid chromatography and mass spectroscopy. She is also working on development some novel formulations and strategies for delivery of anti-infective agents.

Research areas: • Development and validation of chromatographic methods for the assessment of quality and content of antibiotics, amino acids and various other drug substances using liquid chromatography in combination with various detection techniques such as ultra-violet detection, pulsed electrochemical detection, evaporative light scattering detection and capacitively coupled contactless conductivity detection. • Assessing the content of the antibiotics in the biological samples of patients undergoing therapy at the university hospital. • Drug regulatory affairs – India and international regulation. • Ungual & transungual drug delivery systems and strategies

Dr. Shruti Chopra has completed his PhD from Katholieke Universitiet Leuven, Belgium on topic Comparison of different detectors for tobramycin and impurity profiling of tylosin and capreomycin by LC/MS. Sheis Associate Faculty Member at Amity Institute of Indian System of Medicine (AIISM). She has published many papers in reputed journals and has been serving as an editorial board International Journal of Drug Regulatory Affairs(ISSN: 2321-6794).

Research areas: • Development and validation of chromatographic methods for the assessment of quality and content of antibiotics, amino acids and various other drug substances using liquid chromatography in combination with various detection techniques such as ultra-violet detection, pulsed electrochemical detection, evaporative light scattering detection and capacitively coupled contactless conductivity detection. • Assessing the content of the antibiotics in the biological samples of patients undergoing therapy at the university hospital. • Drug regulatory affairs – India and international regulation. • Ungual & transungual drug delivery systems and strategies

Dr. Muhammad Akram has completed his PhD from Hamdard University Karachi-Pakistan and his Area of specialization is “Eastern Medicine (Xanthine Oxidase Inhibition by Plants Extract and Clinical Efficacy of Herbal Formulation in Gouty Arthritis)”. He is the Chairperson, Department of Eastern Medicine, Directorate of Medical Sciences, Faculty of Life Sciences, Government College University Faisalabad-Pakistan He has published papers in reputed journals and has been serving as an editorial board member of repute.

Hyperuricemia, Xanthine oxidase inhibition by some selected medicinal plants, Enzyme Inhibition, Study of traditional system medicine (Indusyunic Medicine) Phytochemistry, and poisonous plants. Bioactivity and phytopharmaceutical evaluation of herb drugs and their natural products, Medicinal plants and Clinical trial, Biochemistry, Bioinformatics

Naji Najib has completed his Ph.D at the age of 28 years from Nottingham University and postdoctoral studies from College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, U.S.A and Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66044, U.S.A. He is the CEO of the International Pharmaceutical Research Center (IPRC), a Clinical Research Organization (CRO). He has published more than 100 papers in reputed journals and serving as an editorial board member of repute journals.

pharmaceutics, Pharmaceutical Chemistry and Clinical Research

Dorota Dobler, Institute of Bioprocess Engineering and Pharmaceutical Technology, Technische Hochschule Mittelhessen-University of Applied Sciences, Wiesenstr. 14, 35390, Giessen, Germany.

Bioprocess Engineering and Pharmaceutical Technology

Mircea Ciuca, MD is currently Global Head of Medical & Clinical Drug Safety at Vifor Pharma in Switzerland. He is leading a team of scientists and physicians involved in all aspects of pharmacovigilance, in both development and post-marketing settings. Mr. Ciuca has about 13 years of experience in drug safety. Prior to join Vifor Pharma he held various positions (Deputy QPPV, Senior Pharmacovigilance Medical Manager, Drug Safety Advisor) at large pharmaceutical companies in The Netherlands, after successfully establishing and leading the medical- scientific department of a medium-size CRO in Rotterdam.

Clinical Drug Safety, clinical practice,Pharmacovigilance

Mircea Ciuca, MD is currently Global Head of Medical & Clinical Drug Safety at Vifor Pharma in Switzerland. He is leading a team of scientists and physicians involved in all aspects of pharmacovigilance, in both development and post-marketing settings. Mr. Ciuca has about 13 years of experience in drug safety. Prior to join Vifor Pharma he held various positions (Deputy QPPV, Senior Pharmacovigilance Medical Manager, Drug Safety Advisor) at large pharmaceutical companies in The Netherlands, after successfully establishing and leading the medical- scientific department of a medium-size CRO in Rotterdam.

Clinical Drug Safety, clinical practice, Pharmacovigilance

Wei-Chiang Shen is currently John A. Biles Professor in Pharmaceutical Sciences at the University of Southern California School of Pharmacy. Dr. Shen's research interests focus on the development of novel systems for improving peptide and protein drug delivery. Current research projects in Dr. Shen's laboratory at USC include (1) recombinant fusion proteins for improving peptide and protein drug delivery, and (2) cell-penetrating peptides for cytosolic or nuclear delivery of macromolecular drugs. Dr. Shen has published 150 papers in different areas of biomedical sciences, including biochemistry, cell biology, pharmaceutics, and immunology. He is an inventor or co-inventor of 16 issued and 2 pending US patents in drug delivery and a co-author of the textbook Immunology for Pharmacy Students and a co-editor of the book Antibody-Drug Conjugates – the 21st Century Magic Bullets for Cancer. Dr. Shen was elected to Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 1992 and Fellow of the American Association for the Advancement of Sciences (AAAS) in 2000, and was the recipient of the Grand Prize of Eurand Award for Outstanding Novel Research in Oral Drug Delivery from Controlled Release Society in 2002.

Pharmaceutics, Drug Delivery, Controlled Release

Vladimir P. Torchilin is a University Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. He graduated from the Moscow University with MS in Chemistry, and obtained there his Ph.D. and D.Sc. in Polymer Chemistry and Chemistry of Physiologically Active Compounds in 1971 and 1980, respectively. In 1991, Dr. Torchilin joined MGH/Harvard Medical School as the Head of Chemistry Program, Center for Imaging and Pharmaceutical Research, and Associate Professor of Radiology. Since 1998 Dr. Torchilin is with Northeastern University. He was the Chair of the Department of Pharmaceutical Sciences in 1998-2008. His research interests include drug delivery and targeting, pharmaceutical nanocarriers. He has published more than 350 original papers, more than 150 reviews and book chapters, wrote and edited 10 books, including Immobilized Enzymes in Medicine, Targeted Delivery of Imaging Agents, Liposomes, Nanoparticulates as Pharmaceutical Carriers, and holds more than 40 patents. He is Editor-in-Chief of Current Drug Discovery Technologies and of Drug Delivery and on the Editorial Boards of many journals including Journal of Controlled Release (Review Editor), Bioconjugate Chemistry, Advanced Drug Delivery Reviews. Among many awards, Professor Torchilin was the recipient of the 1982 Lenin Prize in Science (the highest award in the USSR). He is a Member of European Academy of Sciences. He is also a Fellow of AIMBE, AAPS, and CRS, and received the 2005 Research Achievements in Pharmaceutics and Drug Delivery Award from the AAPS, 2007 Research Achievements Award from the Pharmaceutical Sciences World Congress, 2009 AAPS Journal Award, 2009 International Journal of Nanomedicine Distinguished Scientist Award, 2010 CRS Founders Award, and 2012 Alec Bangham Award. In 2005-2006 he was a President of the Controlled Release Society. In 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2001-2010.

Physiologically active polymers and their use as drug carriers, Targeted delivery of therapeutic and diagnostic agents, Experimental diagnostic imaging, Experimental tumor immunology and therapy and Micellar tumor targeting.

Dr. Amgad M. Rabie, Professor & Researcher of Pharmaceutical Organic (Medicinal) Chemistry & Drug Design/Discovery, Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Pharmacovigilance, Pharmaceutical Industry, Clinical Research, Organic Chemistry, Drug Design, Drug Discovery